Literature DB >> 7898310

A putative model of the dopamine transporter.

O Edvardsen1, S G Dahl.   

Abstract

A three-dimensional model of the human dopamine transporter was constructed by molecular modeling techniques from its amino acid sequence, based on sequence analysis of this and 9 other transporter proteins. The model has 12 membrane spanning alpha-helices arranged in two 7-helical bundles, loops between helices and amino- and carboxy termini. The molecular electrostatic potentials were mainly negative at the synaptic side and positive in the cytoplasmic domains of the transporter model, strongly positive in some of the transmembrane domains, and strongly negative in other transmembrane domains. The model suggests specific binding sites for dopamine and cocaine, a functional role for chloride ions, and accounts for known structure-activity relationships of cocaine analogs at the dopamine transporter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7898310     DOI: 10.1016/0169-328x(94)90009-4

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  4 in total

Review 1.  Monoamine transporter structure, function, dynamics, and drug discovery: a computational perspective.

Authors:  Sankar Manepalli; Christopher K Surratt; Jeffry D Madura; Tammy L Nolan
Journal:  AAPS J       Date:  2012-08-24       Impact factor: 4.009

2.  The binding sites for cocaine and dopamine in the dopamine transporter overlap.

Authors:  Thijs Beuming; Julie Kniazeff; Marianne L Bergmann; Lei Shi; Luis Gracia; Klaudia Raniszewska; Amy Hauck Newman; Jonathan A Javitch; Harel Weinstein; Ulrik Gether; Claus J Loland
Journal:  Nat Neurosci       Date:  2008-06-22       Impact factor: 24.884

3.  Molecular model of the neural dopamine transporter.

Authors:  Aina Westrheim Ravna; Ingebrigt Sylte; Svein G Dahl
Journal:  J Comput Aided Mol Des       Date:  2003 May-Jun       Impact factor: 3.686

4.  Differential binding of tropane-based photoaffinity ligands on the dopamine transporter.

Authors:  R A Vaughan; G E Agoston; J R Lever; A H Newman
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.